Medical Oncologist and Clinician Scientist working on GI Cancer Genomics/Cancer Evolution, Immunotherapies and Biomarkers
Joined November 2014
- Tweets 372
- Following 91
- Followers 1,228
- Likes 88
28 Photos and videos
Marco Gerlinger retweeted
Delighted to host our collaborators @DrHongchengZhu and Dr Xia from Fudan University Hospital at @BartsGI_Cancer this week. Working with Prof @MarcoGerlinger, and Drs @LucyKFlanders, Lerner & Nenclares to improved organ preservation strategies in rectal cancer: 40-50% is in reach
2
5
418
18 Mar 2025
🔥Just opened: 4 year CLINICAL LECTURERSHIP position in HISTOPATHOLOGY @NHSBartsHealth and my lab @QMBCI in London: for ST3/4 registrars who already hold a PhD/MD. Great opportunity for a deep dive into the immunobiology of MMRd cancer. Deadline 11/04 10am oriel.nhs.uk/Web/Vacancy/Vac…
1
2
535
4 Feb 2025
Still time to register for our free @AACR IO webinar today: “Tumour Mutation Burden, Heterogeneity and Immunotherapy Efficacy”with Profs Jaffe, Quezada and Wargo aacr.org/meeting/aacr-io-dis…
4
5
787
29 Jan 2025
Join the discussion: Pervasive Cellular Plasticity intertwined with Darwinian Evolution in Cancer - does this need a new Evolutionary Theory? See our review just out in @trendscancer sciencedirect.com/science/ar…
2
16
40
6,239
11 Dec 2024
Touched down in Miami for the 2024 @CCAlliance #CureCRC Summit - very exciting to be here again to help make this cancer history. Well prepared after lovely Christmas dinner and afternoon tea (‼️‼️) on board of the A380 💪💪💪
2
3
429
Marco Gerlinger retweeted
2 Nov 2024
Starting from International Exchange Award between UK and China supported by @royalsociety, more exciting opportunities have been discussed for collaboration in clinical and translational research between the two premier centers in London and Shanghai 🇬🇧🇨🇳
1
1
14
1,350
Marco Gerlinger retweeted
Kickoff meeting of our new St Barts Hospital - Fudan University Cancer Centre Oesophageal Cancer Research Collaboration in Shanghai today and yesterday. Very grateful to @RoyalSociary for funding this project which is led by Prof @MarcoGerlinger and Prof Zhen Zhang
1
1
6
1,009
4 Jun 2024
Outstanding session with @elena_elez and @BenjcRousseau on immunotherapy biomarkers at @ASCO #ASCO24 this morning. Key messages: Exciting and powerful new IO biomarkers on the horizon. We now need to apply them to large clinical trials including those from industry.
1
12
1,453
Marco Gerlinger retweeted
6 Apr 2024
.@politikaterina will be presenting during the Lineage Plasticity in Tumor Evolution and Acquired Resistance educational session at #AACR24, this morning at 8am PST/11am EST.
abstractsonline.com/pp8/#!/2…
@SmilowCancer @YaleMed @YNHH @yalepathology @YaleThoracic
6
25
5,591
Marco Gerlinger retweeted
6 Apr 2024
What is the role of the TME in lung cancer evolution? We are excited to share our new TRACERx paper “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer” at #AACR24, out in @CD_AACR today rb.gy/q484j9 Tweetorial👇
6
161
505
120,190
Marco Gerlinger retweeted
7 Apr 2024
.@JeffTownsend discussed how the evolution of #cancer is rarely linear, but a branching model that influences progression #AACR24 “Every one of our bodies has a tree of history underlying every cell in our body.” #phylogenetics @AACR @SmilowCancer @YaleMed @YaleSPH
2
12
1,241
7 Apr 2024
Looking forward to meet for a drink (and science discussion of course…)
This tweet is unavailable
399
7 Apr 2024
Important POSTER SESSIONS For those of you at #AACR24:
👉🏻Tumor Evolution in Space and Time is on Monday 9am-12:30 (section 12)
👉🏻Tumor Evolution Models and Technologies on Tuesday 9am-12:30 (section 13)
We received 🏅outstanding 🥇 abstracts this year. Don‘t miss out!!
1
6
539
Marco Gerlinger retweeted
8 Jan 2024
What a great start of 2024! Excited, happy and proud to share our latest work published today #openaccess @NatureMedicine on the PANDA trial: neoadjuvant atezo chemo in pts with gastric/GEJ cancers followed by surgery. Some of the key findings below. 1/10 nature.com/articles/s41591-0…
11
64
208
46,531
Marco Gerlinger retweeted
15 Dec 2023
We're delighted that Prof Tom Powles (@tompowles1) has been selected as one of @Nature's 10 people who shaped science for his transformative clinical work delivering a life-extending treatment for severe bladder cancer.
A huge honour – congratulations to Tom and his team 👏👏👏
Nature's 10 | The people who helped shape science in 2023
An AI pioneer, an architect of India’s Moon mission and the world’s first global heat officer are some of the people behind this year’s big stories.
Check out the full list: nature.com/immersive/d41586-…
#Natures10
1
4
17
2,998
14 Dec 2023
It’s a great honour to be part of the @CCAlliance inaugural #CureCRCsummit this week. Brainstorming strategies to cure #colorectal cancer with giants in the field Drs @skopetz, Batlle, Venook, Lenz, @MyriamChalabi, @AndreaCercek many others
3
9
1,191
Marco Gerlinger retweeted
Important point made in an article in @guardian today: better outcomes for cancer patients who are treated in research active hospitals
2
3
529
15 Nov 2023
-Parallel evolution which surpasses even that in RCC!
-Big headache for biomarker development!
Our study on ITH in dMMR CRCs is out: bit.ly/3SHtxjX
High mutation supply and strong immune selection pressures make this a great model tumor for #CancerEvo studies
4
22
3,314
Marco Gerlinger retweeted
#ESMO23 congress starts tomorrow. @BartsGI_Cancer consultants @rillepihlak and @MarcoGerlinger will be there and tweet 📣 about practice changing trials and 🔥 topics in gastrointestinal cancer! stay tuned
1
3
410